Cargando…
Primary tumor resection and lymph node dissection improve survival in de novo metastatic pancreatic ductal adenocarcinoma: an inverse probability of treatment weighting analysis
BACKGROUND: Primary tumor resection (PTR) and lymph node dissection (LND) may be performed occasionally in patients with de novo metastatic pancreatic ductal adenocarcinoma (mPDAC). However, the role of PTR and LND in such cases remains unclear. Thus, we aimed to test the effect of PTR and LND on ov...
Autores principales: | Wu, Chaorui, Zhang, Xiaojie, Wang, Tongbo, Zhou, Hong, Guo, Chunguang, Chen, Yingtai, Zhao, Dongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798152/ https://www.ncbi.nlm.nih.gov/pubmed/35117698 http://dx.doi.org/10.21037/tcr.2020.04.02 |
Ejemplares similares
-
Neoadjuvant chemotherapy-induced severe neutropenia is associated with histopathological response and survival in locally advanced gastric cancer
por: Wu, Chaorui, et al.
Publicado: (2020) -
Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation
por: Wang, Tongbo, et al.
Publicado: (2021) -
Development and Validation of a New Lymph Node Ratio-Based Staging System for Ampullary Carcinoma After Curative Pancreaticoduodenectomy
por: Zhang, Xiaojie, et al.
Publicado: (2022) -
Impact of the time from the completion of neoadjuvant chemotherapy to surgery on the outcomes of patients with gastric cancer
por: Wu, Chaorui, et al.
Publicado: (2019) -
Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma
por: Li, Zefeng, et al.
Publicado: (2022)